https://doi.org/10.1186/s12933-020-01206-1
N
Nobuichi Kuribayashi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
869
Citations
16
h-index
21
i10-index
Nobuichi Kuribayashi is an academic researcher from Funabashi Orthopaedic Hospital. The author has contributed to research in topics: Diabetes Treatment and Management & Diabetes Management and Research & Metabolism, Diabetes, and Cancer. The author has an h-index of 16, co-authored 40 publications.
Papers by this author
worksEffect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
2021 · Cardiovascular Diabetology · 55 citations
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
2021 · Diabetes Therapy · 23 citations
https://doi.org/10.1007/s13300-021-01125-8
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)
2014 · Diabetology & Metabolic Syndrome · 18 citations
https://doi.org/10.1186/1758-5996-6-35
Relationship between frequency of hypoglycemic episodes and changes in carotid atherosclerosis in insulin-treated patients with type 2 diabetes mellitus
2017 · Scientific Reports · 12 citations
https://doi.org/10.1038/srep39965
Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus
2018 · Diabetes Therapy · 4 citations
https://doi.org/10.1007/s13300-018-0555-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat